Established a reliable biomarker in terms of postoperative adjuvant chemotherapy for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yamada, Daisaku [1 ]
Takeda, Yu [1 ]
Kobayashi, Shogo [1 ]
Sasaki, Kazuki [1 ]
Iwagami, Yoshifumi [1 ]
Tomimaru, Yoshito [1 ]
Noda, Takehiro [1 ]
Takahashi, Hidenori [1 ]
Doki, Yuichiro [1 ]
Eguchi, Hidetoshi [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3309
引用
收藏
页码：2138 / 2138
页数：1
相关论文
共 50 条
  • [41] Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
    Xu, Yongfeng
    Xiong, Qunli
    Yang, Yang
    Weng, Ningna
    Li, Junjun
    Liu, Jinlu
    Yang, Xiaojuan
    Zeng, Zhu
    Zhang, Zhiwei
    Zhu, Qing
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [42] Capillary diameter distribution as a biomarker for pancreatic ductal adenocarcinoma
    Lin, Ken Y.
    Maricevich, Marco
    Weissleder, Ralph
    Mahmood, Umar
    GASTROENTEROLOGY, 2007, 132 (04) : A499 - A499
  • [43] Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy
    Bird, N. T. E.
    Elmasry, M.
    Jones, R.
    Psarelli, E.
    Dodd, J.
    Malik, H.
    Greenhalf, W.
    Kitteringham, N.
    Ghaneh, P.
    Neoptolemos, J. P.
    Palmer, D.
    BRITISH JOURNAL OF SURGERY, 2017, 104 (04) : 328 - 336
  • [44] Myosteatosis to predict postoperative morbidity in pancreatic ductal adenocarcinoma patients receiving neoadjuvant chemotherapy.
    Louie, Raphael
    Aleixo, Gabriel
    Deal, Allison Mary
    Damone, Emily
    Tremont-Portelli, Jaclyn
    Nyrop, Kirsten A.
    Williams, Grant Richard
    Yeh, Jen Jen
    Yu, Hyeon
    Kim, Hong Jin
    Muss, Hyman B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Dynamic evaluation of postoperative survival in pancreatic ductal adenocarcinoma
    Zheng, Bo-Wen
    Yang, Xin-Yu
    Zheng, Jun
    Yao, Ru-Cheng
    MEDICINE, 2025, 104 (12)
  • [46] Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
    Matsushima, Hajime
    Adachi, Tomohiko
    Hidaka, Masaaki
    Yamashita, Mampei
    Hamada, Takashi
    Fukui, Saeko
    Tanaka, Takayuki
    Imamura, Hajime
    Yoshino, Kyohei
    Kugiyama, Tota
    Kitasato, Amane
    Hara, Takanobu
    Soyama, Akihiko
    Kobayashi, Kazuma
    Sumida, Yorihisa
    Kuroki, Tamotsu
    Eguchi, Susumu
    ANTICANCER RESEARCH, 2022, 42 (06) : 3133 - 3141
  • [47] HPB Vitamin D deficiency and Survival in Pancreatic Ductal Adenocarcinoma Patients Who Received Adjuvant Chemotherapy
    Leung, Shun Hay Prudence
    Halle-Smith, James
    Roberts, Keith
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [48] ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma?
    Turner, Kevin M.
    Delman, Aaron M.
    Ammann, Allison M.
    Sohal, Davendra
    Olowokure, Olugbenga
    Choe, Kyuran A.
    Smith, Milton T.
    Kharofa, Jordan R.
    Ahmad, Syed A.
    Wilson, Gregory C.
    Patel, Sameer H.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4622 - 4623
  • [49] The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
    Ghaneh, Paula
    Kleeff, Jorg
    Halloran, Christopher M.
    Raraty, Michael
    Jackson, Richard
    Melling, James
    Jones, Owain
    Palmer, Daniel H.
    Cox, Trevor F.
    Smith, Chloe J.
    O'Reilly, Derek A.
    Izbicki, Jakob R.
    Scarfe, Andrew G.
    Valle, Juan W.
    McDonald, Alexander C.
    Carter, Ross
    Tebbutt, Niall C.
    Goldstein, David
    Padbury, Robert
    Shannon, Jennifer
    Dervenis, Christos
    Glimelius, Bengt
    Deakin, Mark
    Anthoney, Alan
    Lerch, Markus M.
    Mayerle, Julia
    Olah, Attila
    Rawcliffe, Charlotte L.
    Campbell, Fiona
    Strobel, Oliver
    Buechler, Markus W.
    Neoptolemos, John P.
    ANNALS OF SURGERY, 2019, 269 (03) : 520 - 529
  • [50] ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma?
    Kevin M. Turner
    Aaron M. Delman
    Allison M. Ammann
    Davendra Sohal
    Olugbenga Olowokure
    Kyuran A. Choe
    Milton T. Smith
    Jordan R. Kharofa
    Syed A. Ahmad
    Gregory C. Wilson
    Sameer H. Patel
    Annals of Surgical Oncology, 2022, 29 : 4622 - 4623
12345